Amendment: SEC Form SC 13G/A filed by Chewy Inc.

Amendment: SEC Form SC 13G/A filed by Chewy Inc.

Recent Analyst Ratings for $CHWY

$CHWY Analyst Ratings

$CHWY Large Ownership Changes

Chat with this insight

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Chewy upgraded by BofA Securities with a new price target

Chewy upgraded by Citigroup with a new price target

Needham resumed coverage on Chewy

This live feed shows all institutional transactions in real time.

11/6/24 4:39:56 PM ET

$CHWY

Catalog/Specialty Distribution

Consumer Discretionary

Get the next $CHWY alert in real time by email

SC 13G/A 1 d897938dsc13ga.htm SC 13G/A SC 13G/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)*

CHEWY, INC.

(Name of Issuer)

Class A Common Stock, $0.01 par value

(Title of Class of Securities)

16679L109

(CUSIP Number)

September 30, 2024

(Date of Event Which Requires Filing of this Statement)

Check the Appropriate Box to Designate the Rule Pursuant to Which this Schedule Is Filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(1)	Includes 246,525,803 shares of Class A Common Stock that are issuable in exchange for shares of Class B Common Stock on a one-for-one basis.

(2)

Calculated assuming 407,903,481 shares of Class A Common Stock outstanding based upon (i) 161,377,678 shares of Class A Common Stock outstanding as of October 15, 2024, as reported on the Issuer’s Prospectus Supplement filed pursuant to rule 424(b)(7) on September 20, 2024, as increased by (ii) 246,525,803 shares of Class A Common Stock held by the Reporting Persons that are issuable in exchange for shares of Class B Common Stock on a one-for-one basis.

(1)	Includes 246,525,803 shares of Class A Common Stock that are issuable in exchange for shares of Class B Common Stock on a one-for-one basis.

(2)

(1)	Includes 246,525,803 shares of Class A Common Stock that are issuable in exchange for shares of Class B Common Stock on a one-for-one basis.

(2)

(1)	Includes 246,525,803 shares of Class A Common Stock that are issuable in exchange for shares of Class B Common Stock on a one-for-one basis.

(2)

(1)	Includes 246,525,803 shares of Class A Common Stock that are issuable in exchange for shares of Class B Common Stock on a one-for-one basis.

(2)


Item 1(a).		Name of Issuer

		Chewy, Inc. (the “Issuer”)

Item 1(b).		Address of the Issuer’s Principal Executive Offices

		7700 West Sunrise Boulevard
		Plantation, Florida 33322

Item 2(a).		Names of Persons Filing

		This statement is being jointly filed by each of the entities below pursuant to Rule 13d-1(k) promulgated by the Securities and Exchange Commission pursuant to Section 13 of the Act, all of whom together are referred to herein as the “Reporting Persons”:

		(i) BC Partners Holdings Limited

		(ii) CIE Management IX Limited

		(iii) Argos Holdings GP LLC

		(iv) Argos Holdings L.P.

		(v) Citrus Intermediate Holdings L.P.

Item 2(b).		Address of the Principal Business Office, or if none, Residence

		The principal business address of each of the Reporting Persons is as follows:

		650 Madison Avenue
		New York, New York 10022

Item 2(c).		Citizenship

		See responses to Item 4 on each cover page.

Item 2(d).		Title of Class of Securities

		Class A Common Stock, $0.01 par value per share (the “Class A Common Stock”)

Item 2(e).		CUSIP Number

		16679L109

Item 3.		If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a (n):

		Not Applicable.

Item 4.		Ownership
		(a)-(c)

All ownership percentages reported herein are calculated assuming 407,903,481 shares of Class A Common Stock outstanding based upon (i) 161,377,678 shares of Class A Common Stock outstanding as of October 15, 2024, as reported on the Issuer’s Prospectus Supplement filed pursuant to rule 424(b)(7) on September 20, 2024, as increased by (ii) 246,525,803 shares of Class A Common Stock held by the Reporting Persons that are issuable in exchange for shares of Class B Common Stock on a one-for-one basis. The reported amounts and percentages beneficially owned by the Reporting

Persons give effect to the closing of a secondary public offering as reflected in the Issuer’s Prospectus Supplement filed pursuant to rule 424(b)(7) on September 20, 2024, and taking into account the exercise of the underwriter’s overallotment option. Based on these calculations, the Reporting Persons each may be deemed to beneficially own 60.44% of the Issuer’s outstanding shares of Class A Common Stock.

Argos Holdings GP LLC (“GP LLC”) is the general partner of Argos Holdings L.P. (“Argos”). Argos is the sole common equity holder of Citrus Intermediate Holdings L.P. (“Citrus”), which indirectly is the sole equity holder of Citrus Intermediate Topco LLC and Buddy Chester Sub LLC, the direct holders of the reported securities. GP LLC is the general partner of Citrus. CIE Management IX Limited controls a majority of the equity interests of GP LLC and has the power to appoint members to the board of directors of GP LLC who may exercise majority voting power at meetings of the board of directors of GP LLC. BC Partners Holdings Limited is the controlling shareholder of CIE Management IX Limited. Pursuant to Rule 13d-1 of the Act, the Reporting Persons expressly declare that the filing of this statement shall not be construed as an admission that any such person is, for the purposes of Section 13(d) and/or Section 13(g) of the Act or otherwise, the beneficial owner of any securities covered by this statement held by any other person.

Percent of Class:

See responses to Item 11 on each cover page.

Number of shares as to which such person has:

(i)

Sole power to vote or to direct the vote:

See responses to Item 5 on each cover page.

(ii)

Shared power to vote or to direct the vote:

See responses to Item 6 on each cover page.

(iii)

Sole power to dispose or to direct the disposition of:

See responses to Item 7 on each cover page.

(iv)

Shared power to dispose or to direct the disposition of:

See responses to Item 8 on each cover page.


Item 5.		Ownership of Five Percent or Less of a Class

		Not Applicable.

Item 6.		Ownership of More than Five Percent on Behalf of Another Person

		Not Applicable.

Item 7.		Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

		Not Applicable.

Item 8.		Identification and Classification of Members of the Group

		Not Applicable.

Item 9.		Notice of Dissolution of Group

		Not Applicable.

Item 10.		Certification

		Not Applicable.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: November 6, 2024


BC PARTNERS HOLDINGS LIMITED

By:		/s/ Mark Rodliffe
Name:		Mark Rodliffe
Title:		Authorized Signatory

By:		/s/ Karen Jamieson
Name:		Karen Jamieson
Title:		Authorized Signatory

CIE MANAGEMENT IX LIMITED

By:		/s/ Mark Rodliffe
Name:		Mark Rodliffe
Title:		Authorized Signatory

By:		/s/ Matthew Elston
Name:		Matthew Elston
Title:		Authorized Signatory

ARGOS HOLDINGS GP LLC

By:		/s/ Michael Chang
Name:		Michael Chang
Title:		Authorized Signatory

ARGOS HOLDINGS L.P.

By:		/s/ Michael Chang
Name:		Michael Chang
Title:		Authorized Signatory

CITRUS INTERMEDIATE HOLDINGS L.P.

By:		/s/ Michael Chang
Name:		Michael Chang
Title:		Authorized Signatory

EXHIBIT LIST


Exhibit 99.1		Joint Filing Agreement, dated as of February 12, 2024, incorporated herein by reference to Exhibit 99.1 of the statement on Schedule 13G filed by the Reporting Persons on February 12, 2024.

Get the next $CHWY alert in real time by email

Date	Price Target	Rating	Analyst
11/20/2024	$24.00 → $40.00	Underperform → Buy	BofA Securities
11/8/2024	$28.00 → $40.00	Neutral → Buy	Citigroup
10/23/2024		Hold	Needham
10/9/2024	$38.00	Buy	TD Cowen
8/23/2024	$35.00	Overweight	Piper Sandler
8/21/2024		Outperform → Mkt Perform	Raymond James
7/16/2024		Peer Perform	Wolfe Research
7/9/2024		Buy → Hold	Argus

Names of Reporting Persons

BC Partners Holdings Limited

Check The Appropriate Box if a Member of a Group (See Instructions)

(a) ☐ (b) ☒

SEC Use Only

Citizenship or Place of Organization

Guernsey